Review: Is There a Place for Antacids in the Treatment of Helicobacter pylori Infection?

References

• Weberg R., Berstad A., Lange O., Schulz T., Aubert E. Duodenal ulcer healing with four antacid tablets daily. Scand J Gastroenterol 1985; 20: 1041–5
   PubMed Web of Science ®Google Scholar
• Rydning A., Weberg R., Lange O., Berstad A. Healing of benign gastric ulcer with low-dose antacids and fiber diet. Gastroenterology 1986; 91: 56–61
   PubMed Web of Science ®Google Scholar
• Hirschl A., Stanek G., Potzi R., Rotter M., Wende L. Die Empfindlichkeit von Campylobacter pyloridis gegeniiber anti-mikrobiellen Chemotherapeutika und Ulcusterapeutika. Z Antimicrob Antineopl Chemother 1986; 4: 45–9
   Google Scholar
• Berstad A., Alexander B., Weberg R., Serck-Hansen A., Hollander S., Hirschowitz B. I. Antacids reduce Campylobacter pylori colonization without healing the gastritis in patients with non-ulcer dyspepsia and erosive prepyloric changes. Gastroenterology 1988; 95: 619–24
   PubMed Web of Science ®Google Scholar
• Berstad K., Weberg R., Berstad A. Suppression of gastric urease activity by antacids. Scand J Gastroenterol 1990; 25: 496–500
   PubMed Web of Science ®Google Scholar
• Tytgat G. N., Graham D. Y., Lee A., Marshall B. J., Dixon M. F., Axon A. T R. Helicobacter pylori: causal agent in peptic ulcer disease?. J Gastroenterol Hepatol 1991; 6: 103–40
   Web of Science ®Google Scholar
• Marshall B. J., McGechie D. B., Roger P. A., Glancy R. J. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust 1985; 142: 439–44
   PubMed Web of Science ®Google Scholar
• Mobley H. L T, Cortesia M. J., Rosenthal L. E., Jones B. D. Characterization of urease from Campylobacter pylori. J Clin Microbiol 1988; 26: 831–6
   PubMed Web of Science ®Google Scholar
• Blaser M. J., Cover T. L., Steele R., Eaton K., Perez-Perez G., Labigne A. Characteristics of a urease-negative H pylori mutant strain. Rev Esp Enf Digest 1990; 78(Suppl 1)26, P-40B
   Google Scholar
• Smoot D. T., Mobley H. L T, Chippendale G. R., Lewison J. F., Resau J. H. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun 1990; 58: 1992–4
   PubMed Web of Science ®Google Scholar
• Barer M. R., Elliott T. S J, Berkeley D., Thomas J. E., Eastham E. J. Cytopathic effects of Campylobacter pylori urease ‘letter’. J Clin Pathol 1988; 41: 597
   PubMed Web of Science ®Google Scholar
• Xu J.-K., Goodwin S., Cooper M., Robinson J. Intracellular vacuolization caused by the urease of Helicobacter pylori. J Infect Dis 1990; 161: 1302–4
   PubMed Web of Science ®Google Scholar
• Murakami M., Yoo J. K., Teramura S., et al. Generation of ammonia and mucosal lesion formation following hydrolysis of urea by urease in the rat stomach. J Clin Gastroenterol 1990; 12(Suppl 1)S104–9
   Google Scholar
• Marshall B. J., Barret L. J., Prakash C., McCallum R. W., Guerrant R. L. Urea protects Helicobacter pylori from the bactericidal effect of acid. Gastroenterology 1990; 99: 687–702
   Web of Science ®Google Scholar
• Mooney C., Munster D. J., Bagshaw P. F., Allardyce R. A. Helicobacter pylori acid resistance ‘letter’. Lancet 1990; 335: 1232
   PubMed Web of Science ®Google Scholar
• Borody T., Cole P., Noonan S., et al. Long-term Campylobacter pylori recurrence post-eradication. Gastroenterology 1988; 94: A43
   Web of Science ®Google Scholar
• Borody T., Lenne J., Moore-Jones D., et al. Is doxycycline more effective than tetracycline HCI in triple therapy of Helicobacter pylori?. Gastroenterology 1990; 98: A24
   Google Scholar
• McNulty C. A M, Eyre-Brook I. A., Uff I. S., Dent I. C., Wilkinson S. P. Triple therapy is not always 95% effective. The Vth International Workshop on Campylobacter infections. Puerto Vallarta, Mexico February, 1989
   Google Scholar
• Truesdale R. A., Chamberlain C. E., Martin D. F., et al. Long-term follow-up and antibody response to treatment of patients with Helicobacter pylori. Gastroenterology 1999; 98: A140
   Google Scholar
• Bradley B., Singleton M., Li Wan Po A. Review article. Bismuth toxicity: a reassessment. J Clin Pharm Ther 1989; 14: 423–41
   PubMed Web of Science ®Google Scholar
• Berstad K., Wilhelmsen I., Berstad A. Biometric evaluation of gastric urease activity in man. Scand J Gastroenterol 1992; 27: 977–83
   PubMed Web of Science ®Google Scholar
• Statistics with confidence. Confidence intervals and statistical guidelines3rd rev ed., M. J. Gardner, D. G. Altman. British Medical Journal, London 1990
   Google Scholar
• Graham D. Y., Klein P. D., Opekun A. R., et al. In vivo susceptibility of Campylobacter pylori. Am J Gastroenterol 1989; 84: 233–8
   PubMed Web of Science ®Google Scholar
• Hirschl A. M., Hentschel E., Schutze K., et al. The efficacy of antimicrobial treatment in Campylobacter-pylori-associated gastritis and duodenal ulcer. Scand J Gastroenterol 1988; 23(Suppl 142)76–81
   Web of Science ®Google Scholar
• El Nujumi A. M., Dorrian C. A., Chittajallu R. S., Neithercut W. D., McColl K. E L. Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut 1991; 32: 866–70
   PubMed Web of Science ®Google Scholar
• Veldhuyzen van Zanten S. J O, Tytgat K. M A J, Hollingsworth J., et al. 14C-urea breath test for the detection of Helicobacter pylori. Am J Gastroenterol 1990; 85: 399–403
   PubMed Web of Science ®Google Scholar
• Ching C. K. A simplified diagnostic approach to Helicobacter pylori infection–is it adequate? ‘letter’. Am J Gastroenterol 1991; 86: 1276
   PubMed Web of Science ®Google Scholar
• Evans D. J., Evans D. G., Graham D. Y., Klein P. D. A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 1989; 96: 1004–8
   PubMed Web of Science ®Google Scholar
• Kosunen T. U., Hook J., Rautelin H. I., Myllyla G. Age-dependent increase of Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol 1989; 24: 110–4
   PubMed Web of Science ®Google Scholar
• Chiba N., Rademaker J. W., Rao B. V., Hunt R. H. Eradication of Helicobacter pylori–meta-analysis to determine optimal therapy. Gut 1991; 32: A1220–1
   Web of Science ®Google Scholar
• Wilhelmsen I., Berstad A. Duodenal ulcer recurrence after cognitive therapy and after Helicobacter pylori eradication. Scand J Gastroenterol 1992; 27(Suppl 190)A137
   Google Scholar
• Weberg R., Bang C., Berstad K., et al. Treatment of Helicobacter pylori in peptic ulcer disease. Scand J Gastroenterol 1992; 27(Suppl 190)A40
   Google Scholar
• Glupczynski Y., Bourdeaux L., Verhas M., et al. Short-term double or triple oral drug treatment of Helicobacter pylori (Hp) in Central Africa. Gastroenterology 1990; 98: A48
   Google Scholar